Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51
Open Access
- 21 April 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 59 (10) , 4511-4525
Abstract
RAD51 is the central protein in homologous recombination (HR) DNA repair and represents a therapeutic target in oncology. Herein we report a novel class of RAD51 inhibitors that were identified by high throughput screening. In contrast to many previously reported RAD51 inhibitors, our lead compound 1 is capable of blocking RAD51-mediated D-loop formation (IC50 21.3 ± 7.8 μM) at concentrations that do not influence RAD51 binding to ssDNA. In human cells, 1 inhibits HR (IC50 13.1 ± 1.6 μM) without blocking RAD51’s ability to assemble into subnuclear foci at sites of DNA damage. We determined that the active constituent of 1 is actually an oxidized derivative (termed RI(dl)-1 or 8) of the original screening compound. Our SAR campaign also yielded RI(dl)-2 (hereafter termed 9h), which effectively blocks RAD51’s D-loop activity in biochemical systems (IC50 11.1 ± 1.3 μM) and inhibits HR activity in human cells (IC50 3.0 ± 1.8 μM).Keywords
Funding Information
- National Cancer Institute (2 R01 CA142642)
- Wendy Will Case Cancer Fund
This publication has 35 references indexed in Scilit:
- Real-time solution measurement of RAD51- and RecA-mediated strand assimilation without background annealingNucleic Acids Research, 2013
- RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cellsNucleic Acids Research, 2012
- Inhibition of Homologous Recombination in Human Cells by Targeting RAD51 RecombinaseJournal of Medicinal Chemistry, 2012
- Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11Cell, 2011
- Halenaquinone, a chemical compound that specifically inhibits the secondary DNA binding of RAD51Genes to Cells, 2011
- DIDS, a chemical compound that inhibits RAD51-mediated homologous pairing and strand exchangeNucleic Acids Research, 2009
- Use of the Rad51 promoter for targeted anti-cancer therapyProceedings of the National Academy of Sciences, 2008
- A chemical compound that stimulates the human homologous recombination protein RAD51Proceedings of the National Academy of Sciences, 2008
- Alternative-NHEJ Is a Mechanistically Distinct Pathway of Mammalian Chromosome Break RepairPLOS Genetics, 2008
- The consequences of Rad51 overexpression for normal and tumor cellsDNA Repair, 2008